Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies.
Br J Haematol. 2005 Sep;130(6):852-9. doi: 10.1111/j.1365-2141.2005.05690.x.
Br J Haematol. 2005.
PMID: 16156855
Free article.
Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome.
Luesink M, Pennings JL, Wissink WM, Linssen PC, Muus P, Pfundt R, de Witte TJ, van der Reijden BA, Jansen JH.
Luesink M, et al. Among authors: wissink wm.
Blood. 2009 Dec 24;114(27):5512-21. doi: 10.1182/blood-2009-02-204834. Epub 2009 Oct 14.
Blood. 2009.
PMID: 19828696
Free article.
Item in Clipboard
Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1.
Marteijn JA, van der Meer LT, van Emst L, van Reijmersdal S, Wissink W, de Witte T, Jansen JH, Van der Reijden BA.
Marteijn JA, et al. Among authors: wissink w.
Blood. 2007 Nov 1;110(9):3128-35. doi: 10.1182/blood-2006-11-058602. Epub 2007 Jul 23.
Blood. 2007.
PMID: 17646546
Free article.
Item in Clipboard
The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains.
Marteijn JA, van der Meer LT, Smit JJ, Noordermeer SM, Wissink W, Jansen P, Swarts HG, Hibbert RG, de Witte T, Sixma TK, Jansen JH, van der Reijden BA.
Marteijn JA, et al. Among authors: wissink w.
Leukemia. 2009 Aug;23(8):1480-9. doi: 10.1038/leu.2009.57. Epub 2009 Apr 2.
Leukemia. 2009.
PMID: 19340006
Item in Clipboard
Interferon-gamma-based mixed lymphocyte culture as a selection tool for allogeneic bone marrow donors other than identical siblings.
van der Meer A, Wissink WM, Schattenberg AV, Joosten I.
van der Meer A, et al. Among authors: wissink wm.
Br J Haematol. 1999 May;105(2):340-8.
Br J Haematol. 1999.
PMID: 10233402
Free article.
Item in Clipboard
Feasibility of a new in vitro approach to evaluate cellular damage following co-infusion of red blood cell concentrates and intravenous drug solutions.
van den Bos A, Wissink WM, Schattenberg AV, Werre JM, de Pauw BE.
van den Bos A, et al. Among authors: wissink wm.
Clin Lab Haematol. 2003 Jun;25(3):173-8. doi: 10.1046/j.1365-2257.2003.00495.x.
Clin Lab Haematol. 2003.
PMID: 12755794
Item in Clipboard
De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum.
Kuechler A, Willemsen MH, Albrecht B, Bacino CA, Bartholomew DW, van Bokhoven H, van den Boogaard MJ, Bramswig N, Büttner C, Cremer K, Czeschik JC, Engels H, van Gassen K, Graf E, van Haelst M, He W, Hogue JS, Kempers M, Koolen D, Monroe G, de Munnik S, Pastore M, Reis A, Reuter MS, Tegay DH, Veltman J, Visser G, van Hasselt P, Smeets EE, Vissers L, Wieland T, Wissink W, Yntema H, Zink AM, Strom TM, Lüdecke HJ, Kleefstra T, Wieczorek D.
Kuechler A, et al. Among authors: wissink w.
Hum Genet. 2015 Jan;134(1):97-109. doi: 10.1007/s00439-014-1498-1. Epub 2014 Oct 19.
Hum Genet. 2015.
PMID: 25326669
Item in Clipboard
Cite
Cite